American Journal of Psychiatry

PERR, IRWIN N.

doi: 10.1176/appi.ajp.115.3.211pmid: 13571437

IRWIN N. PERR M.D. 1 1 Cleveland Regional Treatment Center, East 124th and Fairhill Rd., Cleveland 20, Ohio. Various aspects of the problem of the premenstrual tension syndrome have been discussed–from medical, psychiatric, and legal viewpoints. The syndrome has been defined with comments on frequency and symptoms with some elaboration on physiological changes and theories of etiology. This in turn has been correlated as much as possible with psychiatric findings, and lastly the relationship of the syndrome to legal considerations has been briefly discussed.

doi: N/Apmid: N/A

EIDUSON, BERNICE T.

doi: 10.1176/appi.ajp.115.3.203pmid: 13571436

BERNICE T. EIDUSON 1 1 The Hacker Foundation for Psychiatric Research and Education, Beverly Hills, Cal. The vigorous experimental work in neurophysiology and neurobiochemistry directs attention toward the structural mechanisms of the central nervous system and particularly to the ways and extent to which these built-in mechanisms order response. The work which has emerged to date has immediate pertinence for some of the problems which have always been crucial ones in personality theory : problems related to how personality is formed, what personality change is and how it is brought about, the nature and significance of individual differences. As the laws of input-organism exchange are extended by subsequent research, and as we begin to think of the therapeutic communication itself as input, we may have to revise sharply our current ways of thinking about the clinical process itself, and some of the notions which are inherent in it. At this point systematic presentations of the clinical and observational data which are the wealth of the clinical psychiatrist would be very helpful in establishing the significance of the neurophysiological findings and even in contributing clues as to the directions in which further advance might lie.

MAGNUS C. PETERSEN, BEVERLY CAREY, and DONALD V. RHOADS

doi: N/Apmid: N/A

William Karliner

doi: N/Apmid: N/A

FREEDMAN, DAVID A.

doi: 10.1176/appi.ajp.115.3.248pmid: 13571446

DAVID A. FREEDMAN M.D. 1 1 The Neuropsychiatric Clinic of the Touro Infirmary, New Orleans, La. From the data presented here, it cannot be concluded that either Harmonyl or reserpine in the doses used is a more effective psychotherapeutic agent than is a placebo of similar physical appearance.

ASHLEY MONTAGU

doi: N/Apmid: N/A

ROBERT L. FAUCETT

doi: N/Apmid: N/A

ARNOLD H. ZUCKER, STANLEY D. MACHLIN, and WINFIELD SCOTT

doi: N/Apmid: N/A

Kate Frankenthal

doi: N/Apmid: N/A